Files
Download Full Text (21.9 MB)
Contents
- Advances Allow Expanded Use of Allogeneic Stem Cell Transplantation
- Use of Umbilical Cord Blood Expands Option of Transplantation to More Children
- House Call: Meeting Your Own Needs While Caring For Someone Else
- Protecting the Interests of Young Donors, by Rebecca Pentz, PhD, Clinical Ethicist
- Protocols: Clinical Trials of Allogeneic Stem Cell Transplants
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.
Publication Date
7-2000
Publisher
The University of Texas MD Anderson Cancer Center
City
Houston, Texas
Keywords
Giralt, Sergio; Khouri, Issa F.; Anderlini, Paolo; Ueno, Naoto T.; Champlin, Richard; Korbling, Martin; Kornblau, Steven; Marini, Frank C.; Chan, Ka Wah, 1949-; de Lima, Marcos; Pentz, Rebecca Davis; Donato, Michele; Stem Cell Transplantation; Graft vs Host Disease; Bone Marrow Transplantation; Cord Blood Stem Cell Transplantation; Drug Therapy; Myeloablative Agonists; Immunosuppression Therapy; fludarabine; Lymphoma; Leukemia, Lymphocytic, Chronic, B-Cell; Hospitalization; Granulocyte Colony-Stimulating Factor; Caregiver Burden; Caregivers; Lymphocytes; Ethics, Clinical; Ethicists; Bioethics; Clinical Trials as Topic.
Disciplines
History of Science, Technology, and Medicine | Oncology
Recommended Citation
Wright, Kerry L.; Chalaire, Dawn; and Pentz, Rebecca D. PhD, "OncoLog, Volume 45, Number 07/08, July/August 2000" (2000). OncoLog MD Anderson's Report to Physicians (All issues). 81.
https://openworks.mdanderson.org/oncolog/81
Conditions Governing Access
Open